过去一年中添加的文章,按日期排序

[HTML][HTML] Breaking the vicious cycle: Targeting the NLRP3 inflammasome for treating sepsis-associated encephalopathy

H Zhong, T Liu, Y Shang, C Huang, S Pan - Biomedicine & …, 2024 - Elsevier
58 天前 - … Importantly, we sought to achieve a deeper understanding of the NLRP3
inflammasome with the ultimate goal of identifying potential therapeutic targets for SAE. …

PLUNC inhibits invasion and metastasis in nasopharyngeal carcinoma by inhibiting NLRP3 inflammasome activation

Q Zhou, Y Guo, Z Tian, Y Qiu, Y Liu, Q Liu, Y Liu… - … et Biophysica Acta (BBA …, 2024 - Elsevier
58 天前 - … However, whether NLRP3 inflammasome activation … PLUNC and NLRP3
inflammasome activation during NPC … by inhibiting the activation of the NLRP3 inflammasome, …

[HTML][HTML] Macrophage α7nAChR alleviates the inflammation of neonatal necrotizing enterocolitis through mTOR/NLRP3/IL-1β pathway

L Shen, X Zhong, H Ji, S Yang, J Jin, C Lyu… - International …, 2024 - Elsevier
61 天前 - … Macrophage α7nAChR activation mitigates NLRP3 inflammasome activation by
modulating mTOR phosphorylation, and subsequently alleviates intestinal inflammation and …

Genetic and epigenetic regulation of inflammasomes: role in atherosclerosis

M Yalcinkaya, AR Tall - Atherosclerosis, 2024 - Elsevier
61 天前 - … Recent work has also shown that NLRP3 inflammasome activation occurs as a result
of … as potential therapeutic targets in ACVD and offers support for the idea that genetically …

[HTML][HTML] Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis

M Wang, Z Huang, X Li, P He, H Sun, Y Peng… - Pharmacological …, 2024 - Elsevier
61 天前 - … and cell pyroptosis linked to NLRP3 inflammasome in HK-2 … leading to the activation
of the NLRP3 inflammasome and … results may provide new perspectives on DKD treatment. …

Rab11b promotes M1-like macrophage polarization by restraining autophagic degradation of NLRP3 in alcohol-associated liver disease

Y Zhao, Y Sun, L Li, X Li, H Li, X Chen, R Xia… - Acta Pharmacologica …, 2024 - nature.com
62 天前 - … , aiming to identify effective therapeutic targets. Here, we … Rab11b specifically
activated the NLRP3 inflammasome in … specifically inhibit NLRP3 inflammasome activation, and …

Therapeutic effect of Sheng Mai San, a traditional Chinese medicine formula, on inflammatory bowel disease via inhibition of NF-κB and NLRP3 inflammasome …

MML Lee, BD Chan, YW Ng, TW Leung… - Frontiers in …, 2024 - frontiersin.org
62 天前 - … SMS also abolished NLRP3 inflammasome activation and inhibited subsequent
caspase-1 activation and IL-1β secretion, suggesting a new therapeutic target for the treatment

Synthesis and Characterization of Histone Deacetylase (HDAC) Inhibitors and PROTACs

F Kraft - 2024 - bonndoc.ulb.uni-bonn.de
62 天前 - … Moreover, prodrugs, which selectively release the drug in the target tissue, have
been … NLRP3 inflammasome activation and their potential use against NLRP3 inflammasome

Screening NLRP3 drug candidates in clinical development: lessons from existing and emerging technologies

IW Tengesdal, M Banks, CA Dinarello… - Frontiers in …, 2024 - frontiersin.org
62 天前 - … their inhibition on NLRP3 activation and NLRP3 inflammasome formation. Of
these three, … NLRP3 is emerging as an attractive therapeutic target to modulate the IL-1-mediated …

Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes

Y Yan, X Ye, C Huang, J Wu, Y Liu… - Journal of Pharmacy …, 2024 - academic.oup.com
63 天前 - activated NLRP3 inflammasome in BMDMs under ATP and nigericin stimulation
conditions after treatment … inhibited the activation of NLRP3 inflammasome induced by ATP and …